scispace - formally typeset
Search or ask a question
Institution

World Health Organization

GovernmentIslamabad, Pakistan
About: World Health Organization is a government organization based out in Islamabad, Pakistan. It is known for research contribution in the topics: Population & Public health. The organization has 13330 authors who have published 22232 publications receiving 1322023 citations. The organization is also known as: World Health Organisation & WHO.


Papers
More filters
Journal ArticleDOI
TL;DR: A rapid and systematic review of the evidence for causality found sufficient evidence to say that Zika virus is a cause of congenital abnormalities and is a trigger of GBS.
Abstract: Background: The Zika virus (ZIKV) caused a large outbreak in the Americas leading to the declaration of a Public Health Emergency of International Concern in February 2016. A causal relation between infection and adverse congenital outcomes such as microcephaly was declared by the World Health Organization (WHO) informed by a systematic review structured according to a framework of ten dimensions of causality, based on the work of Bradford Hill. Subsequently, the evidence has continued to accumulate, which we incorporate in regular updates of the original work, rendering it a living systematic review. Methods: We present an update of our living systematic review on the causal relation between ZIKV infection and adverse congenital outcomes and between ZIKV and GBS for four dimensions of causality: strength of association, dose-response, specificity, and consistency. We assess the evidence published between January 18, 2017 and July 1, 2019. Results: We found that the strength of association between ZIKV infection and adverse outcomes from case-control studies differs according to whether exposure to ZIKV is assessed in the mother (OR 3.8, 95% CI: 1.7-8.7, I 2=19.8%) or the foetus/infant (OR 37.4, 95% CI: 11.0-127.1, I 2=0%). In cohort studies, the risk of congenital abnormalities was 3.5 times higher after ZIKV infection (95% CI: 0.9-13.5, I 2=0%). The strength of association between ZIKV infection and GBS was higher in studies that enrolled controls from hospital (OR: 55.8, 95% CI: 17.2-181.7, I 2=0%) than in studies that enrolled controls at random from the same community or household (OR: 2.0, 95% CI: 0.8-5.4, I 2=74.6%). In case-control studies, selection of controls from hospitals could have biased results. Conclusions: The conclusions that ZIKV infection causes adverse congenital outcomes and GBS are reinforced with the evidence published between January 18, 2017 and July 1, 2019.

382 citations

Journal ArticleDOI
TL;DR: Identification in Rwanda of mutations in Plasmodium falciparum capable of conferring in vitro resistance to artemisinin, an essential medicine for the treatment of malaria, underscore the crucial need for surveillance in Africa to safeguard efficacy of life-saving therapies.
Abstract: Artemisinin resistance (delayed P. falciparum clearance following artemisinin-based combination therapy), is widespread across Southeast Asia but to date has not been reported in Africa1–4. Here we genotyped the P. falciparum K13 (Pfkelch13) propeller domain, mutations in which can mediate artemisinin resistance5,6, in pretreatment samples collected from recent dihydroarteminisin-piperaquine and artemether-lumefantrine efficacy trials in Rwanda7. While cure rates were >95% in both treatment arms, the Pfkelch13 R561H mutation was identified in 19 of 257 (7.4%) patients at Masaka. Phylogenetic analysis revealed the expansion of an indigenous R561H lineage. Gene editing confirmed that this mutation can drive artemisinin resistance in vitro. This study provides evidence for the de novo emergence of Pfkelch13-mediated artemisinin resistance in Rwanda, potentially compromising the continued success of antimalarial chemotherapy in Africa. Identification in Rwanda of mutations in Plasmodium falciparum capable of conferring in vitro resistance to artemisinin, an essential medicine for the treatment of malaria, underscore the crucial need for surveillance in Africa to safeguard efficacy of life-saving therapies.

382 citations

Journal ArticleDOI
TL;DR: A generic reference for fetal weight and birthweight that can be easily adapted to local populations and has a better ability to predict adverse perinatal outcomes than has the non-customised fetal-weight reference, and is simpler to use than the individualised reference without loss of predictive ability.

382 citations

Journal ArticleDOI
TL;DR: It is shown that accurate inference of current transmissibility, and the uncertainty associated with this estimate, requires: up-to-date observations of the serial interval to be included, and cases arising from local transmission to be distinguished from those imported from elsewhere.

381 citations

Journal ArticleDOI
01 Apr 2003-Toxicon
TL;DR: There was much room for improving the production, quality control and safety profile of antivenoms and that lessons could be learnt from the experience gained with the preparation of human immunoglobulins, but international standards and reference materials were not appropriate in the antivenom field.

380 citations


Authors

Showing all 13385 results

NameH-indexPapersCitations
Christopher J L Murray209754310329
Michael Marmot1931147170338
Didier Raoult1733267153016
Alan D. Lopez172863259291
Zulfiqar A Bhutta1651231169329
Simon I. Hay165557153307
Robert G. Webster15884390776
Ali H. Mokdad156634160599
Matthias Egger152901184176
Paolo Boffetta148145593876
Jean Bousquet145128896769
Igor Rudan142658103659
Holger J. Schünemann141810113169
Richard M. Myers134496137791
Majid Ezzati133443137171
Network Information
Related Institutions (5)
Centers for Disease Control and Prevention
82.5K papers, 4.4M citations

92% related

Public Health Research Institute
8.1K papers, 276.9K citations

91% related

Liverpool School of Tropical Medicine
8.6K papers, 325K citations

90% related

Norwegian Institute of Public Health
8.1K papers, 362.8K citations

90% related

University of London
88K papers, 4M citations

89% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
202319
202279
20211,792
20201,612
20191,402
20181,360